Autolus Therapeutics (AUTL) Total Debt (2017 - 2019)

Autolus Therapeutics (AUTL) has reported Total Debt for 3 consecutive years, with $30000.0 the latest figure, recorded in Q3 2019.

• Quarterly Total Debt fell 92.11% year-over-year to $30000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $30000.0 (down 92.11% YoY) and the FY2019 annual result came in at $30000.0, down 92.11% from the prior year.
• Total Debt retreated to $30000.0 in Q3 2019 per AUTL's latest filing, from $121000.0 in the prior quarter.
• Over the last five years, Total Debt for AUTL reached as high as $763000.0 in Q3 2017 and fell as low as $30000.0 in Q3 2019.
• A 3-year average of $315800.0 and a median of $285000.0 in 2018 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2018 — Total Debt tumbled 50.2% — and 2019, when it slumped 92.11%.
• Year by year, Total Debt stood at $763000.0 in 2017, then plunged by 62.65% to $285000.0 in 2018, then plunged by 89.47% to $30000.0 in 2019.
• According to Business Quant data, Total Debt over the past three periods registered $30000.0, $121000.0, and $285000.0 for Q3 2019, Q2 2019, and Q4 2018 respectively.